Background Thromboembolic complications (TECs) are frequent during the endovascular
treatment of unruptured aneurysms. To prevent TECs, dual antiplatelet therapy using aspirin …

BACKGROUND AND PURPOSE: Prophylactic antiplatelet medication is beneficial in
decreasing thromboembolic complications during endovascular treatment of unruptured …

BACKGROUND Antiplatelet premedication is widely accepted for interventional treatment of
cerebral aneurysms to prevent thromboembolism. However, antiplatelet resistance …

Background Thromboembolic events are critical complications in neuroendovascular
procedures, and dual antiplatelet therapy (DAPT) can reduce them. The effects of using …

Background and purpose Variability in response to clopidogrel therapy is increasingly being
recognized as an important factor in thromboembolic and hemorrhagic complications …

BACKGROUND The use of antiplatelet medications to prevent thrombosis in the treatment of
cerebral aneurysms with stents has become widely emphasized. OBJECTIVE To compare …

BACKGROUND: Clopidogrel is routinely used to decrease ischemic complications during
neurointerventional procedures. However, the efficacy may be limited by antiplatelet …

Background Adequate dual antiplatelet (AP) therapy is imperative when performing
neurovascular stenting procedures. Currently, no consensus for the ideal AP regimen exists …

Prevention of intracranial stent thrombosis with dual-antiplatelet therapy is widely used in
neuroendovascular procedures. However, the rising incidence of inadequate platelet …

Background The management of clopidogrel in hyper-responders has not been well
described. We report the treatment and dose adjustment individualization with clopidogrel …